Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China

Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China

Bibliographic Details
Main Authors: Kun-Peng Li, Jing-Yu Jin, Jin-Shui Yang, Yan Li, Wei Zhao, Gui Luo, Jian Zhu, Jiang-Lin Zhang, Feng Huang
Format: Article
Language:English
Published: Termedia Publishing House 2018-06-01
Series:Archives of Medical Science
Subjects:
axial spondyloarthritis
tnf blockers
etanercept biosimilar
dose reduction
remission
Online Access:https://www.termedia.pl/Full-dose-half-dose-or-discontinuation-of-etanercept-biosimilar-in-early-axial-spondyloarthritis-patients-a-real-world-study-in-China,19,32912,1,1.html

Internet

https://www.termedia.pl/Full-dose-half-dose-or-discontinuation-of-etanercept-biosimilar-in-early-axial-spondyloarthritis-patients-a-real-world-study-in-China,19,32912,1,1.html

Similar Items